GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...
Clean water advocate and author Chris Jones formally launched his campaign for Iowa secretary of agriculture Thursday with a ...
We have curated the best innovations of CES 2026, offering a look at standout products that push boundaries, rethink familiar ...
Fetty Wap’s 2026 confinement transfer sets a First Step Act precedent on Earned Time Credits and mandatory minimum ...
News Medical on MSN
A repurposed drug duo shows powerful synergy against liver fibrosis
A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective ...
The onset of the 2026 fiscal year in Ghana has been defined by a profound regulatory and macroeconomic contradiction. On ...
William Dale appointed Chief Financial Officer effective January 12, 2026Simon Oxley to continue as a consultant to XCF ...
The 11 winners were announced during the JEC World Premiere, which took place on Monday 12 January 2026 in Paris and was ...
This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...
The consulting industry is weathering a perfect storm. On one side, artificial intelligence now accomplishes in minutes what ...
The 2026 ACS president will spend the society's 150th anniversary focusing on growing ACS's platform and engaging its members ...
Space.com on MSN
Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
This low-cost mission is still only getting started, and it's taking bigger risks than typical big-ticket NASA missions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results